Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rabe APJ"'
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 16, Pp 1097-1113 (2023)
Adrian Paul J Rabe,1,2 Wei Jie Loke,3 Khushboo Gurjar,4 Allison Brackley,5 Don Eliseo Lucero-Prisno III6,7 1BioPharmaceutical Medical, Respiratory & Immunology, AstraZeneca, Cambridge, UK; 2Imperial College, London, UK; 3East and North Hertfordshire
Externí odkaz:
https://doaj.org/article/98d99c764763448b9b23a32f0a128556
Publikováno v:
International Journal of COPD, Vol Volume 18, Pp 745-754 (2023)
Diana R Tamondong-Lachica,1 Neil Skolnik,2 John R Hurst,3 Nathaniel Marchetti,4 Adrian Paul J Rabe,5,6 Maria Montes de Oca,7 Bartolome R Celli8 1College of Medicine, University of the Philippines Manila, Manila, Philippines; 2Sidney Kimmel Medical Co
Externí odkaz:
https://doaj.org/article/af862a5d7500404bb1140ca08457f6a0
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 83-92 (2018)
Anna Forsythe,1 Patricia S Brandt,2 Mike Dolph,1 Sachin Patel,3 Adrian Paul J Rabe,1 Gabriel Tremblay1 1Purple Squirrel Economics, New York, NY, 2Novartis Pharmaceuticals, East Hanover, NJ, USA; 3Novartis Pharmaceuticals UK Limited, Frimley, Camberle
Externí odkaz:
https://doaj.org/article/c68cffbd1bfc4bb8ad1c809b9b3a744f
Autor:
Jackson DJ; Guy's Severe Asthma Centre, Guy's and Thomas' NHS Trust, London, UK david.jackson@gstt.nhs.uk.; School of Immunology and Microbial Sciences, King's College London, London, UK., Pelaia G; Department of Health Sciences, 'Magna Graecia' University of Catanzaro, Catanzaro, Italy., Emmanuel B; AstraZeneca, Gaithersburg, MD, USA., Tran TN; AstraZeneca, Gaithersburg, MD, USA., Cohen D; AstraZeneca, Gaithersburg, MD, USA., Shih VH; AstraZeneca, Gaithersburg, MD, USA., Shavit A; AstraZeneca, Cambridge, UK., Arbetter D; AstraZeneca, Boston, MA, USA., Katial R; AstraZeneca, Denver, CO, USA., Rabe APJ; AstraZeneca, Cambridge, UK.; Primary Care and Public Health, Imperial College London, London, UK., Garcia Gil E; AstraZeneca, Barcelona, Spain., Pardal M; AstraZeneca, Lisbon, Portugal., Nuevo J; AstraZeneca, Madrid, Spain., Watt M; AstraZeneca, London, UK., Boarino S; AstraZeneca, Milan, Italy., Kayaniyil S; AstraZeneca, Mississauga, ON, Canada., Chaves Loureiro C; Pneumology Unit, Hospitais da Universidade de Coimbra, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.; Centre of Pneumology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Padilla-Galo A; Unidad de Asma, Hospital Costa del Sol, Marbella, Málaga, Spain., Nair P; Division of Respirology, McMaster University, Hamilton, ON, Canada.; Department of Medicine, McGill University, Montreal, QC, Canada.; Firestone Institute for Respiratory Health, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.
Publikováno v:
The European respiratory journal [Eur Respir J] 2024 Jul 11; Vol. 64 (1). Date of Electronic Publication: 2024 Jul 11 (Print Publication: 2024).
Autor:
Rabe APJ; AstraZeneca UK Limited, Cambridge, UK submissions@pshta.com.; Imperial College London, London, London, UK., Loke WJ; Royal Free NHS Trust, London, UK., Kielar D; AstraZeneca UK Limited, Cambridge, UK., Morris T; AstraZeneca UK Limited, Cambridge, UK., Shih VH; AstraZeneca UK Limited, Cambridge, UK., Olinger L; AstraZeneca UK Limited, Cambridge, UK.; Cytel Inc, Waltham, Massachusetts, USA., Musat MG; Cytel Inc, Waltham, Massachusetts, USA., Lan Z; Cytel Inc, Waltham, Massachusetts, USA., Harricharan S; Cytel Inc, Waltham, Massachusetts, USA., Fulton O; BMJ Open Respiratory Research, Edinburgh, UK., Majeed A; Imperial College London, London, London, UK., Heaney LG; Centre of Infection and Immunity, Queens University Belfast, Belfast, UK.
Publikováno v:
BMJ open respiratory research [BMJ Open Respir Res] 2024 May 02; Vol. 11 (1). Date of Electronic Publication: 2024 May 02.
Autor:
Rabe APJ; BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK a.rabe@imperial.ac.uk.; Primary Care and Public Health, Imperial College London, London, UK., Loke WJ; East and North Hertfordshire NHS Trust, Lister Hospital, Stevenage, Hertfordshire, UK., Kalyani RN; BioPharmaceuticals R&D, AstraZeneca US, Gaithersburg, Maryland, USA., Tummala R; BioPharmaceuticals R&D, AstraZeneca US, Gaithersburg, Maryland, USA., Stirnadel-Farrant HA; Oncology Business Unit, Global Medical Affairs, AstraZeneca, Cambridge, UK., Were J; Research Department, Health iQ Limited, London, UK., Winthrop KL; Department of Infectious Diseases, Oregon Health & Science University, Portland, Oregon, USA.
Publikováno v:
BMJ open [BMJ Open] 2023 Nov 22; Vol. 13 (11), pp. e071072. Date of Electronic Publication: 2023 Nov 22.
Autor:
Rabe APJ; Health iQ Ltd, London, UK; Imperial College London, London, UK., Costello P; Sanofi, Berkshire, UK., Were JJ; Health iQ Ltd, London, UK., Farrer A; Health iQ Ltd, London, UK., Hudson RDA; Sanofi, Berkshire, UK. Electronic address: Richard.hudson@sanofi.com.
Publikováno v:
Vaccine [Vaccine] 2022 Nov 15; Vol. 40 (48), pp. 6939-6946. Date of Electronic Publication: 2022 Oct 21.